| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01054721 |
| P698 | PubMed publication ID | 8523088 |
| P2093 | author name string | L White | |
| R Fisher | |||
| V Tobias | |||
| K Sterling-Levis | |||
| P2860 | cites work | Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples | Q24569561 |
| Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures | Q26778382 | ||
| Response to vincristine of recurrent brain tumors in children | Q28333678 | ||
| Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice | Q28336487 | ||
| Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study | Q33374363 | ||
| High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors | Q33396124 | ||
| Carboplatin and recurrent childhood brain tumors | Q33453542 | ||
| Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group | Q33492318 | ||
| Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier | Q34004944 | ||
| The clinical pharmacology of antineoplastic agents (first of two parts). | Q34980885 | ||
| Do anticancer agents reach the tumor target in the human brain? | Q36377551 | ||
| Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study | Q37871379 | ||
| The physiology and pathophysiology of intraocular fluids | Q39712384 | ||
| Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model | Q41887067 | ||
| Experimental chemotherapy of human medulloblastoma with classical alkylators | Q42220630 | ||
| Chemotherapy responsiveness of brain tumors in subrenal capsule assay | Q43976596 | ||
| Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum | Q45103817 | ||
| Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations. | Q45169574 | ||
| In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin | Q48135832 | ||
| Cisplatin in the treatment of recurrent childhood primary brain tumors | Q48166638 | ||
| Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors | Q48266378 | ||
| Potential central nervous system antitumor agents. Aziridinylbenzoquinones | Q48352883 | ||
| Development of a xenograft glioma model in mouse brain. | Q48369573 | ||
| Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG). | Q48373843 | ||
| Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. | Q48379404 | ||
| The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables | Q48483676 | ||
| Human brain tumor xenografts in nude mice as a chemotherapy model | Q48801358 | ||
| Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial | Q48834512 | ||
| A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group | Q48924738 | ||
| High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children | Q49162136 | ||
| Comparison of cyclophosphamide and diaziquone in a retinoblastoma xenograft model. | Q54351870 | ||
| Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion. | Q55485414 | ||
| Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents | Q55486128 | ||
| Development and characterization of human ependymoma xenograft HxBr5. | Q55487254 | ||
| Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. | Q55487789 | ||
| Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. | Q55489910 | ||
| Heterogeneous response to chemotherapy of human gliomas grown in nude mice and as clones in vitro. | Q55490477 | ||
| Responsiveness of retinoblastoma to local diaziquone. Studies in a xenograft model | Q68775136 | ||
| An isotope agarose assay for rapid testing of the sensitivity of glioma biopsies to chemotherapeutic drugs and biological response modifiers. Effects of BCNU, vincristine, lymphokines and the recombinant agents interferon alpha 2c, interferon gamma | Q69032556 | ||
| Evaluation of response to chemotherapy in retinoblastoma heterotransplanted to the eyes of nude mice | Q69936111 | ||
| Heterotransplantation of early B-lineage acute lymphoblastic leukemia using a solubilized attachment matrix (Matrigel) | Q70586631 | ||
| P433 | issue | 1 | |
| P921 | main subject | brain tumor | Q233309 |
| chemotherapy | Q974135 | ||
| xenograft | Q64148587 | ||
| P304 | page(s) | 39-47 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Response of brain tumors to chemotherapy, evaluated in a clinically relevant xenograft model | |
| P478 | volume | 25 |
| Q35021321 | Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas |
| Q35800638 | Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma. |
| Q36395784 | Sepia ink oligopeptide induces apoptosis in prostate cancer cell lines via caspase-3 activation and elevation of Bax/Bcl-2 ratio |
| Q47828906 | The Molecular Mechanisms of Plant-Derived Compounds Targeting Brain Cancer. |
| Q34399296 | What have we learnt from previous phase II trials to help in the management of childhood brain tumours? |
Search more.